Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Orphan Drug 2010 NICHD 1R21HD062749-01 Novel therapeutic strategies for treatment of Angelman Syndrome WEEBER, EDWIN UNIVERSITY OF SOUTH FLORIDA FL $220,500
Orphan Drug 2010 NEI 2R01EY014900-06A2 Ocular Mucsoal Immunity Induced by HSV-1 Lipopeptides BENMOHAMED, LBACHIR UNIVERSITY OF CALIFORNIA IRVINE CA $382,500
Orphan Drug 2010 NCRR 1S10RR026694-01 AB SCIEX QTRAP 5500 System BAKER, SHARYN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $405,039
Orphan Drug 2010 NCRR 1S10RR027656-01 Triple Quadrupole ThermoFisher TSQ Vantage Mass Spectrometer DENNER, LARRY UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $435,992
Orphan Drug 2010 NIA 5R21AG033757-02 High throughput assay development for Huntington?s Disease WETZEL, RONALD UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $186,668
Orphan Drug 2010 NINDS 5R21NS065153-02 Development of a zebrafish assay for the identification of ALS drug targets BEATTIE, CHRISTINE OHIO STATE UNIVERSITY OH $187,782
Orphan Drug 2010 NINDS 5R21NS065352-02 A Forward Genetic Approach To Studying Glioma Formation and Therapy Resistance COLLIER, LARA UNIVERSITY OF WISCONSIN MADISON WI $207,388
Orphan Drug 2010 NCI 5R21CA135166-02 Sensitized screen to identify cooperating genes involved in pancreatic cancer BUCHBERG, ARTHUR THOMAS JEFFERSON UNIVERSITY PA $169,950
Orphan Drug 2010 NIAID 5R01AI073300-02 Trypanosome class II transcription pre-initiation complex GUNZL, ARTHUR UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $382,500
Orphan Drug 2010 NINDS 5R21NS065819-02 EGRF Targeting of Therapeutic Liposomes for Treating Gliobastoma JAMES, CHARLES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $193,125
Orphan Drug 2010 NCI 5R21CA128377-02 Maintenance therapy with decitabine for acute myeloid leukemia in first remission BLUM, WILLIAM OHIO STATE UNIVERSITY OH $330,000
Orphan Drug 2010 NCI 5R21CA140828-02 Enhancement of dendritic cell vaccine efficiency against pancreatic cancer by M-- YAO, QIZHI BAYLOR COLLEGE OF MEDICINE TX $202,620
Orphan Drug 2010 NCI 5R21CA135218-02 Biological and Therapeutic Significance of TG2 in Pancreatic Cancer MEHTA, KAPIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $202,241
Orphan Drug 2010 NCI 5R21CA131756-02 Targeting EMP2 in Endometrial Cancer WADEHRA, MADHURI UNIVERSITY OF CALIFORNIA LOS ANGELES CA $169,400
Orphan Drug 2010 NCI 5R01CA140746-02 Mucus penetrating nanoparticles for early stage cervical cancer HANES, JUSTIN JOHNS HOPKINS UNIVERSITY MD $340,298
Orphan Drug 2010 NCI 5R21CA135830-02 FDG PET and Biomarkers in Treatment Response in Advanced Ovarian Cancer RAJENDRAN, JOSEPH UNIVERSITY OF WASHINGTON WA $342,015
Orphan Drug 2010 NCI 5R21CA137398-02 Anti-tumor properties of curcumin in oral cancers: role of thioredoxin reductase TUTTLE, STEPHEN UNIVERSITY OF PENNSYLVANIA PA $207,902
Orphan Drug 2010 NCI 5R21CA133682-02 Dietary Supplement Selenium and HIF-1alpha Regulation in Cancer BHATTACHARYA, ARUP ROSWELL PARK CANCER INSTITUTE CORP NY $233,333
Orphan Drug 2010 NIAID 5R21AI081107-02 Is phytochelatin synthase an essential enzyme and drug target for schistosomiasis WILLIAMS, DAVID RUSH UNIVERSITY MEDICAL CENTER IL $187,500
Orphan Drug 2010 NCI 5R01CA131946-02 Intervention models for thyroid proliferative disease using a bioactive food comp TIWARI, RAJ NEW YORK MEDICAL COLLEGE NY $329,925
Orphan Drug 2010 NCI 7R21CA140919-02 Targeted CSN5 inhibition in Pancreatic Cancer ZUNDEL, WAYNE OREGON HEALTH AND SCIENCE UNIVERSITY OR $162,799
Orphan Drug 2010 NHLBI 5R01HL095732-02 The LPA Pathway in Lung Fibrosis: Novel Mediators and New Therapeutic Targets TAGER, ANDREW MASSACHUSETTS GENERAL HOSPITAL MA $456,242
Orphan Drug 2010 NIAID 5R21AI083106-02 Virologic and Serologic Outcomes of Persons with HIV and HBV co-infection on Mono ABERG, JUDITH NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $169,000
Orphan Drug 2010 NIAID 5R21AI079361-02 Development of a novel vaccine against congenital cytomegalovirus infection MORELLO, CHRISTOPHER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $231,750
Orphan Drug 2010 NINDS 5R21NS057401-02 Novel Therapeutic Approaches in SBMA MERRY, DIANE THOMAS JEFFERSON UNIVERSITY PA $231,750
Orphan Drug 2010 NCI 5R01CA097048-07 Biomarkers in Phototherapy of Barrett's Esophagus WANG, KENNETH MAYO CLINIC MN $344,973
Orphan Drug 2010 NCI 5R01CA100428-07 Novel Roles of p53 & ROS in Therapy of Refractory CLL HUANG, PENG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $299,699
Orphan Drug 2010 NINDS 5R21NS064223-02 Targeting AMPA Receptor Splicing as a Therapeutic Approach for ALS LUTZ, GORDON DREXEL UNIVERSITY PA $192,394
Orphan Drug 2010 NCI 5R03CA137763-02 iNOS/Akt Inhibotor for Colon Cancer Chemoprevention DESAI, DHIMANT PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $77,186
Orphan Drug 2010 NCI 5R01CA127641-02 Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents FISHER, PAUL VIRGINIA COMMONWEALTH UNIVERSITY VA $310,213
Orphan Drug 2010 NCI 5R01CA126827-02 Synthesis of Anticancer Pyran Natural Products SCHEIDT, KARL NORTHWESTERN UNIVERSITY IL $275,174
Orphan Drug 2010 NHLBI 5R01HL069049-07 Nonviral Gene Medicine for Hemophilia A MIAO, CAROL SEATTLE CHILDREN'S HOSPITAL WA $1,157,090
Orphan Drug 2010 NCI 5R21CA133646-02 Genome instability in leukemia stem cell SKORSKI, TOMASZ TEMPLE UNIVERSITY PA $198,000
Orphan Drug 2010 NIEHS 5R01ES010845-07 Metabolism and Toxicity of Arsenic in the Human Liver STYBLO, MIROSLAV UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $308,003
Orphan Drug 2010 NCI 5R01CA098902-05 TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS VICENTE, MARIA DA GRACA LOUISIANA STATE UNIV A&M COL BATON ROUGE LA $201,520
Orphan Drug 2010 NCI 5R21CA139476-02 Inhibition of Autophagy: A Novel Therapeutic Strategy for Advanced Solid Tumors GILES, FRANCIS UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $321,474
Orphan Drug 2010 NCI 5R01CA103867-08 E2-Cellular Complexes in HPV Chromatin Transcription CHIANG, CHENG-MING UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $282,894
Orphan Drug 2010 NINDS 5R21NS065936-02 Preclinical Development of a Novel Therapeutic Strategy for LGMD2B KHURANA, TEJVIR UNIVERSITY OF PENNSYLVANIA PA $157,500
Orphan Drug 2010 NCI 5R21CA135237-02 Chemoprevention of Tamoxifen-induced Endometrial cancer by black cohosh and red c DIETZ, BIRGIT UNIVERSITY OF ILLINOIS AT CHICAGO IL $172,698
Orphan Drug 2010 NCI 5R01CA104045-07 Chemically Programmed Antibodies for Cancer Therapy BARBAS, CARLOS SCRIPPS RESEARCH INSTITUTE CA $310,063
Orphan Drug 2010 NIA 5R01AG016719-12 Mitochondrial iron-sulfur mechanisms in Friedreich's ataxia CORTOPASSI, GINO UNIVERSITY OF CALIFORNIA DAVIS CA $373,587
Orphan Drug 2010 NIAID 5R01AI070726-02 Retrocyclins: Cyclic mini-defensins that inactivate anthrax toxins LEHRER, ROBERT UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Orphan Drug 2010 NIAID 5R21AI076647-02 Protein Kinases of a Trypanosome MENSA-WILMOT, KOJO UNIVERSITY OF GEORGIA (UGA) GA $222,750
Orphan Drug 2010 NINDS 5R01NS065474-02 Modeling Neurodegeneration and Adrenoleukodystrophy in Drosophila LETSOU, ANTHEA UNIVERSITY OF UTAH UT $361,200
Orphan Drug 2010 NINDS 5R21NS054264-02 GM2 Gangliosidosis Therapy Using Neurotropic Enzyme DOBRENIS, KOSTANTIN ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $227,056
Orphan Drug 2010 NINDS 5R01NS037918-12 Novel Lysosomal Enzyme Deficient in Batten Disease LOBEL, PETER UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $429,000
Orphan Drug 2010 NIAID 5U01AI082202-02 Chimeric Alphavirus Vaccines for Chikungunya WEAVER, SCOTT UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $945,118
Orphan Drug 2010 NCI 5U01CA120458-05 Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors BLAGG, BRIAN UNIVERSITY OF KANSAS LAWRENCE KS $355,744
Orphan Drug 2010 NCI 5R01CA100098-06 Targeted Proapoptotic Anticancer Drug Delivery Systems MINKO, TAMARA RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $424,329
Orphan Drug 2010 NIAMS 5R01AR041880-16 Biogenesis of Melanosomes ORLOW, SETH NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $422,500
Orphan Drug 2010 NIAID 5R03AI083933-02 New Approaches to Cervical Cancer Prevention in India KULASINGAM, SHALINI UNIVERSITY OF MINNESOTA TWIN CITIES MN $78,750
Orphan Drug 2010 NCI 5R21CA141840-02 Dosimetry Guided Phase II of 90Y-DOTA-tyr3-Octreotide + Retinoic Acid in Kids O'DORISIO, M. SUE UNIVERSITY OF IOWA IA $265,346
Orphan Drug 2010 NHLBI 5R01HL091082-02 Differential regulation of cardiomyocyte survival and hypertrophy ERHARDT, PETER BOSTON BIOMEDICAL RESEARCH INSTITUTE MA $585,472
Orphan Drug 2010 NIDCR 5R21DE019232-02 Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node Metastasis ROSENTHAL, EBEN UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $219,750
Orphan Drug 2010 OD 1RC3MD005194-01 Nikkomycin Z treatment of early coccidioidal pneumonia: Phase II clinical trial GALGIANI, JOHN VALLEY FEVER SOLUTIONS, INC. AZ $2,999,834
Orphan Drug 2010 NCI 1RC3CA150730-01 Episcleral Chemotherapy as Salvage Therapy for Eyes with Retinoblastoma CARVALHO, RICARDO TARGETED THERAPY TECHNOLOGIES, LLC NJ $2,769,464
Orphan Drug 2010 OD 1R43GM093748-01 Novel SCID rat models for human cell transplantation studies RUIZ, JOSEPH TRANSPOSAGEN BIOPHARMACEUTICALS, INC. KY $174,707
Orphan Drug 2010 OD 1R43CA150742-01 Novel multivalent/multifunctional agents derived from a humanized anti-insulin-li CARDILLO, THOMAS IMMUNOMEDICS, INC. NJ $192,688
Orphan Drug 2010 NIAID 5F32AI084323-02 Identifying Host-Factors Required for Toxin Entry and Toxicity HETT, ERIK MASSACHUSETTS GENERAL HOSPITAL MA $52,154
Orphan Drug 2010 NIAID 5U01AI082079-02 Development of Aptamer-Based Therapy Against HUS TZIPORI, SAUL TUFTS UNIVERSITY BOSTON MA $664,732
Orphan Drug 2010 NHLBI 5R01HL093981-02 Novel Cellular Therapies for Ph+ leukemia VAN ETTEN, RICHARD TUFTS MEDICAL CENTER MA $724,784
Orphan Drug 2010 NIGMS 5R01GM070852-05 Molecular Approaches to Understanding Global Regulation in Paclitaxel Accumulatio ROBERTS, SUSAN UNIVERSITY OF MASSACHUSETTS AMHERST MA $366,636
Orphan Drug 2010 NIAID 5U01AI077949-02 Novel antiobiotic development for biodefense JOHNSON, MICHAEL UNIVERSITY OF ILLINOIS AT CHICAGO IL $1,991,637
Orphan Drug 2010 NIAID 5U01AI078015-02 Tetravalent dengue vaccine based on complex adenovirus vectors RAVIPRAKASH, KANAKATTE HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $763,587
Orphan Drug 2010 NIAID 5U01AI082164-02 Development and Formulation of Broad Spectrum Antimicrobials for Biodefense SLAYDEN, RICHARD COLORADO STATE UNIVERSITY-FORT COLLINS CO $978,895
Orphan Drug 2010 NIAID 5R42AI066618-03 TLR Signal Inhibition: A Novel Therapeutic Paradigm KOHN, LEONARD INTERTHYR CORPORATION OH $1,322,092
Orphan Drug 2010 NINDS 5R01NS066945-02 MION for Synchronized MRI and Drug Therapy of Brain Tumor YANG, VICTOR UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $384,888
Orphan Drug 2010 NHLBI 5RC1HL100579-02 Let-7 miRNA control of heart development HATCHER, CATHY WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $497,446
Orphan Drug 2010 NIDDK 5R01DK080095-02 Pathology of the FSGS Kidney FOGO, AGNES VANDERBILT UNIVERSITY TN $350,135
Orphan Drug 2010 NIDCR 5RC1DE020332-02 Development and Profiling of Human-in-Mouse Models of Salivary Carcinomas YARBROUGH, WENDELL VANDERBILT UNIVERSITY TN $311,763
Orphan Drug 2010 NHLBI 1R15HL103431-01 Anti-PAH Drugs in Inhalable Nanoparticles for Sustained Pulmonary Vasodilation AHSAN, FAKHRUL TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $428,533
Orphan Drug 2010 OD 5RC1CA146337-02 Targeted Photoactivatable Nanocells to Image and Treat Metastic Ovarian Cancer HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $474,804
Orphan Drug 2010 NIAID 5R01AI082542-02 Drug Discovery Consortium for Chagas Disease TARLETON, RICK UNIVERSITY OF GEORGIA (UGA) GA $1,078,742
Orphan Drug 2010 NIDDK 5RC1DK086542-02 Exon capture and large-scale sequencing for disease-cause identification, early d HILDEBRANDT, FRIEDHELM UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $490,729
Orphan Drug 2010 NINDS 5R21NS067975-02 Gene Targeted Therapy of Brain Tumors SAMPSON, JOHN DUKE UNIVERSITY NC $194,754
Orphan Drug 2010 NINDS 5RC1NS068391-02 Transgenic Mouse Models of FUS/TLS-Mediated Amyotrophic Lateral Sclerosis HAYWARD, LAWRENCE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $499,740
Orphan Drug 2010 NINDS 5RC1NS068963-02 Development of Small Molecule Orexin Receptor Agonists for Treating Narcolepsy DE BRABANDER, JEF UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $487,799
Orphan Drug 2010 NIDCR 5RC2DE020957-02 Genone-wide Discovery of Molecular Alterations in Head and Neck Cancer SIDRANSKY, DAVID JOHNS HOPKINS UNIVERSITY MD $626,283
Orphan Drug 2010 OD 5RC2DE020957-02 Genone-wide Discovery of Molecular Alterations in Head and Neck Cancer SIDRANSKY, DAVID JOHNS HOPKINS UNIVERSITY MD $626,282
Orphan Drug 2010 NINDS 5RC1NS068131-02 Identification of Compounds to treat Charcot-Marie-Tooth type 2E neuropathy LIEM, RONALD COLUMBIA UNIVERSITY HEALTH SCIENCES NY $409,260
Orphan Drug 2010 NINDS 5RC1NS069234-02 New Frontiers in OPMD: Stem Cell Theory of Oculopharyngeal Muscular Dystrophy PAVLATH, GRACE EMORY UNIVERSITY GA $500,000
Orphan Drug 2010 OD 5RC1EB010384-02 Volumetric Perfusion MRI of Liver Tumors to Detect Early Response to Chemotherapy REEDER, SCOTT UNIVERSITY OF WISCONSIN MADISON WI $485,299
Orphan Drug 2010 NINDS 5RC2NS069476-02 Delivery of therapeutic genes in motor neuron disease BURGHES, ARTHUR OHIO STATE UNIVERSITY OH $1,674,836
Orphan Drug 2010 OD 5RC1AR058333-02 Identification of Enhancers of Therapeutic Exon Skipping for DMD MICELI, M UNIVERSITY OF CALIFORNIA LOS ANGELES CA $497,653
Orphan Drug 2010 NIDDK 5RC1DK086956-02 Reactivation of Fetal Gamma-globin Genes for the Treatment of Beta-globin Disorde TANABE, OSAMU UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $491,467
Orphan Drug 2010 NHLBI 5RC1HL100159-02 Phase 2a Study of Ataluren in Hemophilia A and B (IND 104,321) BARTH, JAY PTC THERAPEUTICS, INC. NJ $498,215
Orphan Drug 2010 NINDS 5RC1NS070675-02 Genotype and Metabolic Phenotype in Glioblastoma MAHER, ELIZABETH UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $500,000
Orphan Drug 2010 NIAMS 5RC2AR058947-02 An allosteric inhibitor of ZAP-70 as a novel therapeutic for autoimmune disease WEISS, ARTHUR UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $881,498
Orphan Drug 2010 NINDS 5RC2NS069395-02 Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells ROTHSTEIN, JEFFREY JOHNS HOPKINS UNIVERSITY MD $1,837,375
Orphan Drug 2010 NIAMS 5RC1AR058613-02 A reconstructed skin model for development of treatments for albinism ORLOW, SETH NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $454,676
Orphan Drug 2010 NCI 5RC2CA148325-02 A Therapeutic Vaccine for EBV-Associated Malignancies LIEBERMAN, PAUL WISTAR INSTITUTE PA $495,303
Orphan Drug 2010 NCI 5R21CA133879-02 GTI-2040: An anti-sense strategy to reduce ribonucleotide reductase in AML MARCUCCI, GUIDO OHIO STATE UNIVERSITY OH $335,500
Orphan Drug 2010 NICHD 5R21HD060899-02 Motor neuron generation from SMA patient-derived induced pluripotent stem cells EBERT, ALLISON UNIVERSITY OF WISCONSIN MADISON WI $185,625
Orphan Drug 2010 NINDS 5R21NS067147-02 AMPA receptor attenuation as a new therapeutic approach for Batten disease PEARCE, DAVID SANFORD RESEARCH/USD SD $207,500
Orphan Drug 2010 NINDS 5RC2NS069422-02 The Huntington's Disease iPS Consortium THOMPSON, LESLIE UNIVERSITY OF CALIFORNIA IRVINE CA $1,839,894
Orphan Drug 2010 NCI 5RC2CA148529-02 Targeted Therapies for Childhood Acute Lymphoblastic Leukemia REAMAN, GREGORY NATIONAL CHILDHOOD CANCER FOUNDATION CA $438,096
Orphan Drug 2010 OD 5RC2CA148529-02 Targeted Therapies for Childhood Acute Lymphoblastic Leukemia REAMAN, GREGORY NATIONAL CHILDHOOD CANCER FOUNDATION CA $438,098
Orphan Drug 2010 NCI 5RC1CA145707-02 GENOMIC ANALYSIS OF ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $500,000
Orphan Drug 2010 NCI 5RC2CA147820-02 Targeting MCPyV to Overcome Immune Evasion in Merkel Cell Carcinoma NGHIEM, PAUL UNIVERSITY OF WASHINGTON WA $500,000
Orphan Drug 2010 NCI 5RC2CA148260-02 Translational Research Studies in Clinical Trials of Novel Therapeutics for Sarco MAKI, ROBERT SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $592,225
Orphan Drug 2010 OD 5RC2CA148260-02 Translational Research Studies in Clinical Trials of Novel Therapeutics for Sarco MAKI, ROBERT SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $592,224
Orphan Drug 2010 OD 5RC1AR058189-02 MR Monitoring of PTC124 Treatment in DMD VANDENBORNE, KRISTA UNIVERSITY OF FLORIDA FL $454,895
Orphan Drug 2010 NCI 5RC1CA146882-02 Developing a prediction model for vincristine-induced peripheral neuropathy RENBARGER, JAMIE INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $493,455
Orphan Drug 2010 OD 5RC1CA145075-02 RADIATION-ENHANCED NANOBIOPOLYMER THERAPEUTICS THROUGH THE BLOOD-BRAIN BARRIER KAO, GARY UNIVERSITY OF PENNSYLVANIA PA $498,770
Orphan Drug 2010 NCI 5RC2CA149024-02 Development of a novel vaccine for protection against gammaherpesvirus infection DAMANIA, BLOSSOM UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $499,659
Orphan Drug 2010 NCI 5RC1CA145010-02 Human in Mouse Modeling of HNSCC to Predict Resonse to Therapy YARBROUGH, WENDELL VANDERBILT UNIVERSITY TN $377,139
Orphan Drug 2010 NCI 5RC2CA148348-02 Development of Vaccine Strategies to prevent EBV+ Lymphoma in Patients with HIV BAIOCCHI, ROBERT OHIO STATE UNIVERSITY OH $500,000
Orphan Drug 2010 NCI 5RC2CA148394-02 Lung Cancer Mutation Analysis BUNN, PAUL UNIVERSITY OF COLORADO DENVER CO $1,172,626
Orphan Drug 2010 OD 5RC2CA148394-02 Lung Cancer Mutation Analysis BUNN, PAUL UNIVERSITY OF COLORADO DENVER CO $1,172,624
Orphan Drug 2010 NCI 5RC2CA148268-02 Functional Annotation of Cancer Genomes: TCGA, Glioblastoma and Ovarian Cancer HAHN, WILLIAM DANA-FARBER CANCER INSTITUTE MA $2,998,170
Orphan Drug 2010 NCI 5RC2CA148308-02 Systems Biology of Tumor Progression and Drug-Resistance CALIFANO, ANDREA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $2,204,251
Orphan Drug 2010 NCI 5RC2CA148431-02 Proteasome/HDAC Inhibition in Leukemia/MDS; Phase I Trial and Correlative Studies GRANT, STEVEN VIRGINIA COMMONWEALTH UNIVERSITY VA $589,802
Orphan Drug 2010 NEI 5RC1EY020274-02 Regulated Transgene Expression in the Retina WILSON, JAMES UNIVERSITY OF PENNSYLVANIA PA $496,479
Orphan Drug 2010 OD 5RC1EY020361-02 Development of Small Heat Shock Proteins as Therapeutic Agents in the Eye PETRASH, JONATHAN UNIVERSITY OF COLORADO DENVER CO $493,174
Orphan Drug 2010 NIDDK 3R01DK077162-03S1 NBC1 and Proximal RTA: Pathogenesis and Treatment KURTZ, IRA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $92,437
Orphan Drug 2010 NIDDK 3K01DK063992-05S1 Gene therapy for Cooley's anemia in a new mouse model RIVELLA, STEFANO WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $54,000
Orphan Drug 2010 NIDDK 3R01DK064969-06S2 CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY MCCARTHY, ELLEN UNIVERSITY OF KANSAS MEDICAL CENTER KS $150,000
Orphan Drug 2010 NCI 261200800001E-26-0-46 New Therapeutic Molecules ARTHUR, LARRY SAIC-FREDERICK, INC. MD $8,000,000
Orphan Drug 2010 NCI 1RC4CA156449-01 Pharmacogenomics of Racial Disparities in Childhood Leukemia Outcomes RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $1,731,842
Orphan Drug 2010 NIAID 1RC4AI092624-01 Development of novel therapeutics for a neglected tropical disease leishmaniasis SATOSKAR, ABHAY OHIO STATE UNIVERSITY OH $2,626,966
Orphan Drug 2010 OD 1RC4CA156509-01 YK-4-279 specifically targets ETS family fusion-protein cancers in clinical trial TORETSKY, JEFFREY GEORGETOWN UNIVERSITY DC $4,374,674
Orphan Drug 2010 NINDS 1RC4NS073009-01 Drug Discovery for Spinocerebellar Ataxia Type 2 (SCA2) PULST, STEFAN UNIVERSITY OF UTAH UT $834,912
Orphan Drug 2010 NCI 3U10CA098543-08S1 Children's Oncology Group Chair's Grant REAMAN, GREGORY NATIONAL CHILDHOOD CANCER FOUNDATION CA $498,467
Orphan Drug 2010 NCI 3U10CA031946-29S1 Cancer and Leukemia Group B BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL MA $411,230
Orphan Drug 2010 NIAID 3U01AI070384-04S1 Cooperative Research Partnership for an Amebic Colitis Vaccine PETRI, WILLIAM UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $61,195
Orphan Drug 2010 NIAID 3R01AI080326-01A2S1 Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV Model KIEM, HANS-PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $13,265
Orphan Drug 2010 NIAID 3U19AI029530-18S1 6222 Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant SOIFFER, ROBERT DANA-FARBER CANCER INSTITUTE MA $313,737
Orphan Drug 2010 NIAID 3R01AI071223-03S1 Experimental Molecular Vaccines for Schistosomiasis SIDDIQUI, AFZAL TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $33,413
Orphan Drug 2010 NIAID 1R56AI090803-01 Discovery of novel antileishmanial molecules from the plant Pentalinon andreuxii SATOSKAR, ABHAY OHIO STATE UNIVERSITY OH $803,969
Orphan Drug 2010 NIAID 1R56AI090564-01 Multiplex serodiagnostic test for Chagas disease TARLETON, RICK UNIVERSITY OF GEORGIA (UGA) GA $782,492
Orphan Drug 2010 NIAID 3R01AI054384-20S1 Biochemistry of Protein Prenylation GELB, MICHAEL UNIVERSITY OF WASHINGTON WA $37,986
Orphan Drug 2010 NIAID 3R01AI073672-03S1 Typhoid priority antigen identification and vaccine development MCSORLEY, STEPHEN UNIVERSITY OF MINNESOTA TWIN CITIES MN $182,835
Orphan Drug 2010 NIAID 3R01AI071223-03S2 Experimental Molecular Vaccines for Schistosomiasis SIDDIQUI, AFZAL TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $307,630
Orphan Drug 2010 NINDS 3R21NS064223-02S1 Targeting AMPA Receptor Splicing as a Therapeutic Approach for ALS LUTZ, GORDON DREXEL UNIVERSITY PA $76,959
Orphan Drug 2010 NIDDK 1R56DK084984-01A1 Molecular Mechanisms of the Inflammatory Response Induced by Shigella flexneri MCCORMICK, BETH UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $411,250
Orphan Drug 2010 NIAID 1R56AI089491-01 GMP Production of a Human Monoclonal Antibody for the Treatment of HUS AKIYOSHI, DONNA TUFTS UNIVERSITY BOSTON MA $1,303,141
Orphan Drug 2010 NIAID 3R01AI063058-06A1S1 Mechanism and regulation of DNA end processing in V(D)J recombination and repair SEKIGUCHI, JOANN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $142,664
Orphan Drug 2010 NIEHS 5P42ES010344-07 5984 Project 3: Genetic and Epigenetic Mechanisms of Toxicities of Mixtures of WIRGIN, ISAAC NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $182,525
Orphan Drug 2010 NIAID 3R01AI080928-02S1 Biodegradable Nanoparticles for Targeted Antibiotic Delivery PANYAM, JAYANTH UNIVERSITY OF MINNESOTA TWIN CITIES MN $55,460
Orphan Drug 2010 NIAID 5U54AI082973-02 8799 Survival and Disease Correction Following Hematopoietic Cell Transplantation of W FILIPOVICH, ALEXANDRA CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $129,023
Orphan Drug 2010 NCI 3R01CA138738-02S1 Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells BRENTJENS, RENIER SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $1,951,470
Orphan Drug 2010 NCI 3U10CA098543-08S5 Children's Oncology Group Chair's Grant REAMAN, GREGORY NATIONAL CHILDHOOD CANCER FOUNDATION CA $976,412
Orphan Drug 2010 NINDS 3RC2NS069395-02S1 Generation and Characterization of Amyotrophic Lateral Sclerosis iPS cells ROTHSTEIN, JEFFREY JOHNS HOPKINS UNIVERSITY MD $82,000
Orphan Drug 2010 NINDS 3RC2NS069422-02S1 The Huntington's Disease iPS Consortium THOMPSON, LESLIE UNIVERSITY OF CALIFORNIA IRVINE CA $76,500
Orphan Drug 2010 NCRR 3P30CA014599-35S5 9023 HUMAN IMMUNOLOGIC MONITORING GAJEWSKI, THOMAS UNIVERSITY OF CHICAGO IL $33,122
Orphan Drug 2010 NCRR 3P30CA023108-32S4 5667 IMMUNOLOGY AND CANCER IMMUNOTHERAPY RESEARCH PROGRAM NOELLE, RANDOLPH DARTMOUTH COLLEGE NH $17,790
Orphan Drug 2010 NCRR 3P30CA013330-38S1 9032 IMMUNO-ONCOLOGY SCHARFF, MATTHEW ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $6,886
Orphan Drug 2010 NCRR 3P30CA016086-34S7 9044 CORE--PROTOCOL-SPECIFIC RESEARCH MITCHELL, BEVERLY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $30,345


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer